methylprednisolone has been researched along with Duncan Disease in 27 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (3.70) | 18.7374 |
| 1990's | 8 (29.63) | 18.2507 |
| 2000's | 11 (40.74) | 29.6817 |
| 2010's | 7 (25.93) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kanda, T; Kawai, M; Koga, M; Maeda, T; Ogasawara, JI; Omoto, M; Sano, H | 1 |
| Chin, YP; Lai, WF; Liu, CW; Tsai, CY | 1 |
| Fan, L; Li, JY; Shi, K; Wang, L; Xia, Y; Xu, W; Zhu, HY | 1 |
| Daniels, H; Delforge, M; Martens, PJ | 1 |
| Colgan, JP; Habermann, TM; Holtan, SG; Markovic, SN; Porrata, LF; Zent, CS | 1 |
| Aw, MM; Dhawan, A; Heaton, N; Mieli-Vergani, G; Rela, M; Verma, A | 1 |
| Aozasa, K; Hatachi, S; Kunitomi, A; Yagita, M | 1 |
| Dubinsky, M; Gidrewicz, D; Lehman, D; Majlessipour, F; Rabizadeh, S | 1 |
| Arnon, R; Kerkar, N; Miloh, T; Tomaino, J; Weiner, C; Weintraub, L; Wistinghausen, B | 1 |
| Brière, J; Dardenne, S; Detry, R; Emile, FJ; Fabiani, B; Gaulard, P; Guiot, Y; Michaux, L; Theate, I | 1 |
| Ayash, L; Becker, M; Braun, T; Cooke, KR; Ferrara, JL; Hutchinson, R; Jones, D; Levine, JE; Ratanatharathorn, V; Reddy, P; Reynolds, C; Silver, S; Uberti, JP; Whitfield, J; Yanik, G | 1 |
| Culligan, DJ; Johnston, PW; Milner, BJ; Mittal, S | 1 |
| Butler, J; Durrant, S; Hill, GR; Kennedy, GA; Morton, J; Western, R | 1 |
| Ito, Y; Mitsuo, K; Tanaka, K; Tateishi, T | 1 |
| Jacobs, P; Mansvelt, E; Moodley, D; Ruff, P; Wood, L | 1 |
| Blanche, S; de Saint Basile, G; Fischer, A; Mahlaoui, N; Neven, B; Ouachée-Chardin, M; Picard, C | 1 |
| Hattori, M; Ikezumi, Y; Okubo, S; Shiraga, H; Suzuki, T; Takahashi, K; Uchiyama, M | 1 |
| Ali, SA; Levenson, BM; Mittal, N; Muthukumar, A; Payne, DA; Timmons, CF | 1 |
| Cockfield, SM; Jewell, LD; Parfrey, NA; Preiksaitis, JK | 1 |
| David, M; Hodak, E; Sandbank, M; Trattner, A | 1 |
| Cavallo, R; Giacchino, F; Merlino, C; Negro Ponzi, A; Re, D; Segoloni, G; Sinesi, F; Tognarelli, G | 1 |
| Alliaudi, C; Bonissoni, S; Bragardo, M; Buonfiglio, D; Correra, A; Dianzani, I; Dianzani, U; DiFranco, D; Ramenghi, U; Redoglia, V; Scagni, P | 1 |
| Alonso, EM; Kelly, SM; Newell, KA; Rubin, CM; Thistlethwaite, JR; Whitington, PF | 1 |
| Ament, M; Busuttil, R; Goss, J; McDiarmid, S; Seu, P; Shackleton, C; Vargas, J | 1 |
| Born, G; Froschauer, R; Gralka, S; Hohenberger, W; Köckerling, F; Müller, V; Ott, R; Reck, T | 1 |
| Diaz-Mitoma, F; Mirzayans, F; Preiksaitis, JK; Roberts, S; Tyrrell, DL | 1 |
| Akihama, T; Chubachi, A; Endo, Y; Kuwayama, A; Miura, A; Yoshida, K | 1 |
1 review(s) available for methylprednisolone and Duncan Disease
| Article | Year |
|---|---|
[Chronic T-cell lymphoproliferative disorder associated with pure red cell aplasia].
Topics: Adult; Azathioprine; Combined Modality Therapy; Cyclophosphamide; Female; Humans; Lymphoproliferative Disorders; Methylprednisolone; Prednisolone; Red-Cell Aplasia, Pure; Remission Induction; Splenectomy; T-Lymphocytes | 1989 |
1 trial(s) available for methylprednisolone and Duncan Disease
| Article | Year |
|---|---|
Pilot trial on the use of etanercept and methylprednisolone as primary treatment for acute graft-versus-host disease.
Topics: Adolescent; Adult; Anti-Inflammatory Agents; Bone Marrow Transplantation; Child; Drug Therapy, Combination; Etanercept; Female; Graft vs Host Disease; Humans; Immunoglobulin G; Immunosuppressive Agents; Lymphoproliferative Disorders; Male; Methylprednisolone; Middle Aged; Pilot Projects; Receptors, Tumor Necrosis Factor; Receptors, Tumor Necrosis Factor, Type I; Tacrolimus; Transplantation, Homologous; Tumor Necrosis Factor-alpha | 2005 |
25 other study(ies) available for methylprednisolone and Duncan Disease
| Article | Year |
|---|---|
Steroid-responsive demyelinating peripheral neuropathy associated with chronic lymphoproliferative disorders of natural killer cells.
Topics: Administration, Oral; Aged; Biomarkers; Chronic Disease; Demyelinating Diseases; Female; Humans; Killer Cells, Natural; Lymphoproliferative Disorders; Methylprednisolone; Peripheral Nervous System Diseases; Prednisolone; Pulse Therapy, Drug; Receptors, IgG; Sural Nerve; Treatment Outcome | 2017 |
Methotrexate-associated lymphoproliferative disease with multiple pulmonary nodules in a patient with rheumatoid arthritis.
Topics: Administration, Intravenous; Aftercare; Antigens, CD20; Antirheumatic Agents; Arthritis, Rheumatoid; Female; Glucocorticoids; Humans; Lymphoproliferative Disorders; Methotrexate; Methylprednisolone; Middle Aged; Multiple Pulmonary Nodules; Sjogren's Syndrome; Treatment Outcome | 2017 |
[High-dose methylprednisolone with Rituximab and fresh frozen plasma in the treatment of six patients with B-cell lymphoproliferative disorders harboring TP53 abnormalities].
Topics: Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Mantle-Cell; Lymphoproliferative Disorders; Methylprednisolone; Rituximab; Tumor Suppressor Protein p53 | 2019 |
Lymphoproliferative associated type 1 cryoglobulinemia.
Topics: Aged, 80 and over; Biopsy; Cryoglobulinemia; Humans; Immunoglobulin M; Immunohistochemistry; Lymphoproliferative Disorders; Male; Methylprednisolone; Penicillanic Acid; Piperacillin; Rituximab; Tazobactam | 2016 |
mTOR inhibitor monotherapy is insufficient to suppress viremia and disease progression in Epstein-Barr virus-driven lymphoproliferative disorders (EBV-LPD).
Topics: Aged; Disease Progression; Drug Therapy, Combination; Female; Herpesvirus 4, Human; Humans; Immunoglobulins, Intravenous; Lymphoproliferative Disorders; Male; Methylprednisolone; Middle Aged; Protein Kinases; Sirolimus; TOR Serine-Threonine Kinases; Treatment Failure; Viremia | 2008 |
Long-term outcome of mycophenolate mofetil rescue therapy for resistant acute allograft rejection in pediatric liver transplant recipients.
Topics: Adolescent; Child; Child, Preschool; Female; Graft Rejection; Humans; Immunosuppressive Agents; Infant; Liver Transplantation; Lymphoproliferative Disorders; Male; Methylprednisolone; Mycophenolic Acid; Retrospective Studies; Treatment Outcome | 2008 |
CD8(+) T-cell lymphoproliferative disorder associated with Epstein-Barr virus in a patient with rheumatoid arthritis during methotrexate therapy.
Topics: Acyclovir; Aged; Antirheumatic Agents; Antiviral Agents; Arthritis, Rheumatoid; CD8-Positive T-Lymphocytes; Epstein-Barr Virus Infections; Female; Gene Rearrangement, beta-Chain T-Cell Antigen Receptor; Herpesvirus 4, Human; Humans; Immunocompromised Host; Immunophenotyping; Lymph Nodes; Lymphoproliferative Disorders; Meningoencephalitis; Methotrexate; Methylprednisolone | 2010 |
Primary EBV infection resulting in lymphoproliferative disease in a teenager with Crohn disease.
Topics: Adolescent; Anti-Inflammatory Agents; Antibodies, Monoclonal; Azathioprine; Crohn Disease; Epstein-Barr Virus Infections; Female; Humans; Immunosuppressive Agents; Infliximab; Lymphoproliferative Disorders; Methylprednisolone | 2011 |
Graft rejection in pediatric liver transplant patients with Epstein-Barr viremia and post-transplant lymphoproliferative disease.
Topics: Adolescent; Antiviral Agents; Child; Child, Preschool; Epstein-Barr Virus Infections; Female; Follow-Up Studies; Graft Rejection; Humans; Immunosuppressive Agents; Infant; Liver Transplantation; Lymphoproliferative Disorders; Male; Methylprednisolone; Postoperative Complications; Reoperation; Retrospective Studies; Risk Factors; Treatment Outcome; Viremia; Young Adult | 2012 |
Epstein-Barr virus-associated lymphoproliferative disease occurring in a patient with sarcoidosis treated by methotrexate and methylprednisolone.
Topics: Anti-Inflammatory Agents; Epstein-Barr Virus Infections; Herpesvirus 4, Human; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Lymphoproliferative Disorders; Male; Methotrexate; Methylprednisolone; Middle Aged; Sarcoidosis, Pulmonary | 2002 |
A case of hepatosplenic gamma-delta T-cell lymphoma with a transient response to fludarabine and alemtuzumab.
Topics: Adolescent; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Crohn Disease; Cytarabine; Epirubicin; Epstein-Barr Virus Infections; Etoposide; Fatal Outcome; Gene Rearrangement, delta-Chain T-Cell Antigen Receptor; Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Immunosuppressive Agents; Liver; Lymphoma, T-Cell, Peripheral; Lymphoproliferative Disorders; Male; Methylprednisolone; Pentostatin; Receptors, Antigen, T-Cell, gamma-delta; Remission Induction; Spleen; Transplantation, Homologous; Vidarabine | 2006 |
Combination antithymocyte globulin and soluble TNFalpha inhibitor (etanercept) +/- mycophenolate mofetil for treatment of steroid refractory acute graft-versus-host disease.
Topics: Acute Disease; Adolescent; Adult; Anti-Inflammatory Agents; Antilymphocyte Serum; Disease-Free Survival; Drug Resistance; Drug Therapy, Combination; Etanercept; Female; Graft vs Host Disease; Humans; Immunoglobulin G; Immunosuppression Therapy; Immunosuppressive Agents; Infections; Lymphoproliferative Disorders; Male; Methylprednisolone; Middle Aged; Mycophenolic Acid; Receptors, Tumor Necrosis Factor; Recurrence; Retrospective Studies; Salvage Therapy | 2006 |
[Case of X-linked lymphoproliferative syndrome (XLP) with multiple nodular lesions in the brain].
Topics: Adult; Brain; Humans; Lung; Lymphohistiocytosis, Hemophagocytic; Lymphoproliferative Disorders; Magnetic Resonance Imaging; Male; Methylprednisolone; Prednisolone; Pulse Therapy, Drug; Tomography, X-Ray Computed; Treatment Outcome; Vasculitis, Central Nervous System | 2006 |
Amyloidosis: a changing clinical perspective.
Topics: Adult; Aged; Amyloidosis; Antibodies, Monoclonal; Bone Marrow; Bone Marrow Transplantation; Colchicine; Diagnosis, Differential; Disease Management; Female; Humans; Immunotherapy; Lymphoproliferative Disorders; Male; Melphalan; Methylprednisolone; Middle Aged; Plasma Cells; Prednisone; Radioimmunotherapy; South Africa; Survival Rate | 2007 |
Immunotherapy of familial hemophagocytic lymphohistiocytosis with antithymocyte globulins: a single-center retrospective report of 38 patients.
Topics: Adrenal Cortex Hormones; Antilymphocyte Serum; Child; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Immunotherapy; Infections; Injections, Spinal; Lymphohistiocytosis, Hemophagocytic; Lymphoproliferative Disorders; Male; Methotrexate; Methylprednisolone; Recurrence; Retrospective Studies; Treatment Outcome | 2007 |
Epstein-Barr virus DNA load and seroconversion in pediatric renal transplantation with tacrolimus immunosuppression.
Topics: Child; DNA, Viral; Epstein-Barr Virus Infections; Female; Herpesvirus 4, Human; Humans; Immunosuppressive Agents; Kidney Transplantation; Living Donors; Lymphoproliferative Disorders; Male; Methylprednisolone; Mycophenolic Acid; Polymerase Chain Reaction; Tacrolimus; Viral Load | 2007 |
Unusual case of Epstein-Barr virus DNA tissue positive: blood negative in a patient with post-transplant lymphoproliferative disorder.
Topics: Child; DNA, Viral; Female; Graft Rejection; Herpesvirus 4, Human; Humans; Immunoglobulins, Intravenous; Liver Transplantation; Lymphocytes; Lymphoproliferative Disorders; Methylprednisolone; Polymerase Chain Reaction; Viral Load | 2009 |
Post-transplant lymphoproliferative disorder in renal allograft recipients. Clinical experience and risk factor analysis in a single center.
Topics: Adult; Antilymphocyte Serum; Graft Rejection; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Transplantation; Lymphoproliferative Disorders; Male; Methylprednisolone; Middle Aged; Muromonab-CD3; Postoperative Complications; Retrospective Studies; Risk Factors | 1993 |
The appearance of Kaposi sarcoma during corticosteroid therapy.
Topics: Adult; Aged; Autoimmune Diseases; Azathioprine; Betamethasone; Female; Humans; Lymphoproliferative Disorders; Male; Methylprednisolone; Middle Aged; Prednisone; Sarcoma, Kaposi; Skin Neoplasms; Triamcinolone | 1993 |
[Epstein-Barr virus infection and lymphoproliferative disorders in patients after renal transplantation].
Topics: Adult; Antibodies, Viral; Cyclosporine; Cytomegalovirus Infections; Female; Glucocorticoids; Herpesviridae Infections; Herpesvirus 4, Human; Humans; Immunosuppressive Agents; Kidney Transplantation; Lymphoproliferative Disorders; Male; Methylprednisolone; Middle Aged; Postoperative Complications | 1996 |
Deficiency of the Fas apoptosis pathway without Fas gene mutations in pediatric patients with autoimmunity/lymphoproliferation.
Topics: Adolescent; Adult; Apoptosis; Autoimmune Diseases; Ceramides; Child, Preschool; Consanguinity; DNA Mutational Analysis; DNA, Complementary; fas Receptor; Female; Humans; Infant; Lymphocyte Activation; Lymphoproliferative Disorders; Male; Methylprednisolone; Polymorphism, Single-Stranded Conformational; Purpura, Thrombocytopenic, Idiopathic; Signal Transduction; Sphingomyelin Phosphodiesterase; T-Lymphocyte Subsets; Thrombocytopenia | 1997 |
Association between liver transplantation for Langerhans cell histiocytosis, rejection, and development of posttransplant lymphoproliferative disease in children.
Topics: Adolescent; Age Factors; Antiviral Agents; Azathioprine; Child; Child, Preschool; Cyclosporine; Follow-Up Studies; Ganciclovir; Glucocorticoids; Graft Rejection; Herpesviridae Infections; Herpesvirus 4, Human; Histiocytosis, Langerhans-Cell; Humans; Immunosuppressive Agents; Incidence; Liver Failure; Liver Transplantation; Lymphoproliferative Disorders; Methylprednisolone; Muromonab-CD3; Prednisone; Recurrence; Retrospective Studies; Risk Factors; Survival Rate; Tacrolimus; Tumor Virus Infections | 1997 |
One hundred children treated with tacrolimus after primary orthotopic liver transplantation.
Topics: Child; Child, Preschool; Drug Administration Schedule; Follow-Up Studies; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Liver Transplantation; Lymphoproliferative Disorders; Methylprednisolone; Muromonab-CD3; Mycophenolic Acid; Postoperative Complications; Prednisone; Retrospective Studies; Survival Rate; Tacrolimus; Time Factors | 1998 |
Low rejection rate after hepatic transplantation achieved with a cyclosporine-based quadruple immunosuppressive regimen.
Topics: Adult; Antilymphocyte Serum; Cyclosporine; Cytomegalovirus Infections; Drug Monitoring; Drug Therapy, Combination; Graft Rejection; Hepatitis B; Hepatitis C; Humans; Immunosuppressive Agents; Incidence; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Lymphoproliferative Disorders; Methylprednisolone; Monitoring, Immunologic; Neoplasms, Second Primary; Opportunistic Infections; Postoperative Complications; Retrospective Studies | 1998 |
Quantitative oropharyngeal Epstein-Barr virus shedding in renal and cardiac transplant recipients: relationship to immunosuppressive therapy, serologic responses, and the risk of posttransplant lymphoproliferative disorder.
Topics: Adolescent; Adult; Antilymphocyte Serum; Azathioprine; Cyclosporine; DNA, Viral; Female; Follow-Up Studies; Genotype; Graft Rejection; Heart Transplantation; Heart-Lung Transplantation; Herpesvirus 4, Human; Humans; Immunosuppression Therapy; Kidney Transplantation; Lymphoproliferative Disorders; Male; Methylprednisolone; Middle Aged; Mouth; Pharynx; Polymerase Chain Reaction; Prednisone; Risk Factors; Time Factors; Transplantation, Homologous | 1992 |